Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion

Maria Teresa Gandolfo, Hye Ryoun Jang, Serena M. Bagnasco, Gang Jee Ko, Patricia Agreda, Mark J. Soloski, Michael T. Crow, Hamid Rabb

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Lymphocytes participate in the early pathogenesis of ischemia-reperfusion injury (IRI) in kidney; however, their role during repair is largely unknown. Recent data have shown that Foxp3+ regulatory T cells (Tregs) traffic into kidney during healing from IRI and directly participate in repair. Since lymphocyte-targeting therapy is currently administered to prevent rejection during recovery from IRI in renal transplants, we hypothesized that mycophenolate mofetil (MMF) would alter Treg trafficking and kidney repair. C57BL/6J and T cell deficient mice underwent unilateral clamping of renal pedicle for 45min, followed by reperfusion, and were sacrificed at day 10. Mice were treated with saline (C) or MMF (100mg/kg) i.p. daily starting at day 2 until sacrifice (n=5-12/group). MMF worsened kidney tubular damage compared to C at 10days (cortex and outer medulla: p<0.05) in wild-type mice; tubular apoptotic index was increased in cortex in MMF group as well (p=0.01). MMF reduced the total number of kidney-infiltrating mononuclear cells (p<0.001 versus C) and the percentages of TCRβ+CD4+ and TCRβ+CD8+ T cells (p<0.01), but not natural killer (NK), NKT or B lymphocytes. MMF specifically reduced kidney Foxp3+ Tregs (0.82±0.11% versus 1.75±0.17%, p<0.05). Tubular proliferative index and tissue levels of basic FGF were increased in MMF group (p<0.05), IL-10 and IL-6 were decreased (p<0.05). To evaluate if MMF effect occurred through non-lymphocytic cells, T cell deficient mice were treated with MMF. Tubular injury in T cell deficient mice was not affected by MMF treatment, though MMF-treated animals had increased VEGF and decreased PDGF-BB protein tissue levels compared to controls (p<0.05). Thus, MMF modifies the structural, epithelial proliferative and inflammatory response during healing, likely through effects on T cells and possibly Tregs. Kidney repair after IRI can be altered by agents that target lymphocytes.

Original languageEnglish
Pages (from-to)45-52
Number of pages8
JournalTransplant Immunology
Volume23
Issue number1-2
DOIs
Publication statusPublished - 2010 May 1
Externally publishedYes

Fingerprint

Mycophenolic Acid
Regulatory T-Lymphocytes
Reperfusion
Ischemia
Kidney
Wounds and Injuries
Reperfusion Injury
T-Lymphocytes
Lymphocytes
Constriction
Interleukin-10
Vascular Endothelial Growth Factor A
Interleukin-6

Keywords

  • Ischemia-reperfusion injury
  • Kidney
  • Lymphocyte
  • Mycophenolate mofetil
  • Repair

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Transplantation

Cite this

Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion. / Gandolfo, Maria Teresa; Jang, Hye Ryoun; Bagnasco, Serena M.; Ko, Gang Jee; Agreda, Patricia; Soloski, Mark J.; Crow, Michael T.; Rabb, Hamid.

In: Transplant Immunology, Vol. 23, No. 1-2, 01.05.2010, p. 45-52.

Research output: Contribution to journalArticle

Gandolfo, Maria Teresa ; Jang, Hye Ryoun ; Bagnasco, Serena M. ; Ko, Gang Jee ; Agreda, Patricia ; Soloski, Mark J. ; Crow, Michael T. ; Rabb, Hamid. / Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion. In: Transplant Immunology. 2010 ; Vol. 23, No. 1-2. pp. 45-52.
@article{77b7af60a91e45749e74c7007cda99c6,
title = "Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion",
abstract = "Lymphocytes participate in the early pathogenesis of ischemia-reperfusion injury (IRI) in kidney; however, their role during repair is largely unknown. Recent data have shown that Foxp3+ regulatory T cells (Tregs) traffic into kidney during healing from IRI and directly participate in repair. Since lymphocyte-targeting therapy is currently administered to prevent rejection during recovery from IRI in renal transplants, we hypothesized that mycophenolate mofetil (MMF) would alter Treg trafficking and kidney repair. C57BL/6J and T cell deficient mice underwent unilateral clamping of renal pedicle for 45min, followed by reperfusion, and were sacrificed at day 10. Mice were treated with saline (C) or MMF (100mg/kg) i.p. daily starting at day 2 until sacrifice (n=5-12/group). MMF worsened kidney tubular damage compared to C at 10days (cortex and outer medulla: p<0.05) in wild-type mice; tubular apoptotic index was increased in cortex in MMF group as well (p=0.01). MMF reduced the total number of kidney-infiltrating mononuclear cells (p<0.001 versus C) and the percentages of TCRβ+CD4+ and TCRβ+CD8+ T cells (p<0.01), but not natural killer (NK), NKT or B lymphocytes. MMF specifically reduced kidney Foxp3+ Tregs (0.82±0.11{\%} versus 1.75±0.17{\%}, p<0.05). Tubular proliferative index and tissue levels of basic FGF were increased in MMF group (p<0.05), IL-10 and IL-6 were decreased (p<0.05). To evaluate if MMF effect occurred through non-lymphocytic cells, T cell deficient mice were treated with MMF. Tubular injury in T cell deficient mice was not affected by MMF treatment, though MMF-treated animals had increased VEGF and decreased PDGF-BB protein tissue levels compared to controls (p<0.05). Thus, MMF modifies the structural, epithelial proliferative and inflammatory response during healing, likely through effects on T cells and possibly Tregs. Kidney repair after IRI can be altered by agents that target lymphocytes.",
keywords = "Ischemia-reperfusion injury, Kidney, Lymphocyte, Mycophenolate mofetil, Repair",
author = "Gandolfo, {Maria Teresa} and Jang, {Hye Ryoun} and Bagnasco, {Serena M.} and Ko, {Gang Jee} and Patricia Agreda and Soloski, {Mark J.} and Crow, {Michael T.} and Hamid Rabb",
year = "2010",
month = "5",
day = "1",
doi = "10.1016/j.trim.2010.04.002",
language = "English",
volume = "23",
pages = "45--52",
journal = "Transplant Immunology",
issn = "0966-3274",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion

AU - Gandolfo, Maria Teresa

AU - Jang, Hye Ryoun

AU - Bagnasco, Serena M.

AU - Ko, Gang Jee

AU - Agreda, Patricia

AU - Soloski, Mark J.

AU - Crow, Michael T.

AU - Rabb, Hamid

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Lymphocytes participate in the early pathogenesis of ischemia-reperfusion injury (IRI) in kidney; however, their role during repair is largely unknown. Recent data have shown that Foxp3+ regulatory T cells (Tregs) traffic into kidney during healing from IRI and directly participate in repair. Since lymphocyte-targeting therapy is currently administered to prevent rejection during recovery from IRI in renal transplants, we hypothesized that mycophenolate mofetil (MMF) would alter Treg trafficking and kidney repair. C57BL/6J and T cell deficient mice underwent unilateral clamping of renal pedicle for 45min, followed by reperfusion, and were sacrificed at day 10. Mice were treated with saline (C) or MMF (100mg/kg) i.p. daily starting at day 2 until sacrifice (n=5-12/group). MMF worsened kidney tubular damage compared to C at 10days (cortex and outer medulla: p<0.05) in wild-type mice; tubular apoptotic index was increased in cortex in MMF group as well (p=0.01). MMF reduced the total number of kidney-infiltrating mononuclear cells (p<0.001 versus C) and the percentages of TCRβ+CD4+ and TCRβ+CD8+ T cells (p<0.01), but not natural killer (NK), NKT or B lymphocytes. MMF specifically reduced kidney Foxp3+ Tregs (0.82±0.11% versus 1.75±0.17%, p<0.05). Tubular proliferative index and tissue levels of basic FGF were increased in MMF group (p<0.05), IL-10 and IL-6 were decreased (p<0.05). To evaluate if MMF effect occurred through non-lymphocytic cells, T cell deficient mice were treated with MMF. Tubular injury in T cell deficient mice was not affected by MMF treatment, though MMF-treated animals had increased VEGF and decreased PDGF-BB protein tissue levels compared to controls (p<0.05). Thus, MMF modifies the structural, epithelial proliferative and inflammatory response during healing, likely through effects on T cells and possibly Tregs. Kidney repair after IRI can be altered by agents that target lymphocytes.

AB - Lymphocytes participate in the early pathogenesis of ischemia-reperfusion injury (IRI) in kidney; however, their role during repair is largely unknown. Recent data have shown that Foxp3+ regulatory T cells (Tregs) traffic into kidney during healing from IRI and directly participate in repair. Since lymphocyte-targeting therapy is currently administered to prevent rejection during recovery from IRI in renal transplants, we hypothesized that mycophenolate mofetil (MMF) would alter Treg trafficking and kidney repair. C57BL/6J and T cell deficient mice underwent unilateral clamping of renal pedicle for 45min, followed by reperfusion, and were sacrificed at day 10. Mice were treated with saline (C) or MMF (100mg/kg) i.p. daily starting at day 2 until sacrifice (n=5-12/group). MMF worsened kidney tubular damage compared to C at 10days (cortex and outer medulla: p<0.05) in wild-type mice; tubular apoptotic index was increased in cortex in MMF group as well (p=0.01). MMF reduced the total number of kidney-infiltrating mononuclear cells (p<0.001 versus C) and the percentages of TCRβ+CD4+ and TCRβ+CD8+ T cells (p<0.01), but not natural killer (NK), NKT or B lymphocytes. MMF specifically reduced kidney Foxp3+ Tregs (0.82±0.11% versus 1.75±0.17%, p<0.05). Tubular proliferative index and tissue levels of basic FGF were increased in MMF group (p<0.05), IL-10 and IL-6 were decreased (p<0.05). To evaluate if MMF effect occurred through non-lymphocytic cells, T cell deficient mice were treated with MMF. Tubular injury in T cell deficient mice was not affected by MMF treatment, though MMF-treated animals had increased VEGF and decreased PDGF-BB protein tissue levels compared to controls (p<0.05). Thus, MMF modifies the structural, epithelial proliferative and inflammatory response during healing, likely through effects on T cells and possibly Tregs. Kidney repair after IRI can be altered by agents that target lymphocytes.

KW - Ischemia-reperfusion injury

KW - Kidney

KW - Lymphocyte

KW - Mycophenolate mofetil

KW - Repair

UR - http://www.scopus.com/inward/record.url?scp=77953806657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953806657&partnerID=8YFLogxK

U2 - 10.1016/j.trim.2010.04.002

DO - 10.1016/j.trim.2010.04.002

M3 - Article

VL - 23

SP - 45

EP - 52

JO - Transplant Immunology

JF - Transplant Immunology

SN - 0966-3274

IS - 1-2

ER -